Disc Medicine, Inc. (IRON)
$56.60-6.42%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.2B
- Beta
- 2.05
- P/E (TTM)
- -8.45
- Short % float
- 26.47%
- Days to cover
- 12.8
- SI change
- +0.9%
- 1W
- -8.19%
- 1M
- -17.88%
- vs SPY 1W
- -8.05%
- vs SPY 1M
- -20.38%
Industry peers
FMP comparable companies · ranked by market cap
- PTGXSELLProtagonist Therapeutics, Inc.$8.8BRECOVERYQ 32$136.28-4.41%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.8BRECOVERYQ 4$30.97-1.98%
- COAGSELLHemab Therapeutics Holdings, Inc. Common Stock$1.4BQ -10$29.94-1.94%
- DMRASELLDamora Therapeutics, Inc.$1.1BCRISISQ -5$18.43-8.39%
- GERNSELLGeron Corporation$765MRECOVERYQ 11$1.19-1.64%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IRON?
- LOPJLB’s latest quantitative signal on Disc Medicine, Inc. (IRON) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IRON in?
- Disc Medicine, Inc. (IRON) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Disc Medicine, Inc. (IRON) do?
- Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by…